Accès gratuit
Editorial
Numéro
Méd. Intensive Réa.
Volume 28, Numéro 3, Juin 2019
infectieux
Page(s) 199 - 201
Section Éditorial / Editorial
DOI https://doi.org/10.3166/rea-2019-0102
Publié en ligne 26 mai 2019
  • Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, Manuel R, Brown CS, (2018) Candida auris: a review of the literature. Clin Microbiol Rev 31: 41. doi: 10.1128/CMR.00029-17 [Google Scholar]
  • Clancy CJ, Nguyen MH, (2017) Emergence of Candida auris: an international call to arms. Clin Infect Dis 64: 141–143. doi: 10.1093/cid/ciw696 [CrossRef] [PubMed] [Google Scholar]
  • Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, Newnham R, Sunderland M, Clarke T, Foster D, Hoffman P, Borman AM, Johnson EM, Moore G, Brown CS, Walker AS, Peto TEA, Crook DW, Jeffery KJM, (2018) A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 379: 1322–1331. doi: 10.1056/NEJMoa1714373 [Google Scholar]
  • Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F; French Mycosis Study Group, (2017) Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002–2014). J Antimicrob Chemother 72: 1784–1793. doi: 10.1093/jac/dkx045 [CrossRef] [PubMed] [Google Scholar]
  • Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group, (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med 40: 1303–1312. doi: 10.1007/s00134-014-3408-3 [CrossRef] [PubMed] [Google Scholar]
  • Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, Barrett PM, Kerins JL, Lockhart SR, Chiller TM, Litvintseva AP; US Candida auris Investigation Team, (2018) Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis 18: 1377–1384. doi: 10.1016/S1473-3099(18)30597-8 [CrossRef] [PubMed] [Google Scholar]
  • Chowdhary A, Sharma C, Meis JF, (2017) Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 13: e1006290. doi: 10.1371/journal.ppat.1006290 [CrossRef] [PubMed] [Google Scholar]
  • Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M, (2017) The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61: 41. doi: 10.1128/AAC.02396-16 [Google Scholar]
  • Desoubeaux G, Bailly E, Guillaume C, De Kyvon MA, Tellier AC, Morange V, Bernard L, Salamé E, Quentin R, Chandenier J, (2018) Candida auris in contemporary mycology labs: a few practical tricks to identify it reliably according to one recent French experience. J Mycol Med 28: 407–410. doi: 10.1016/j.mycmed.2018.02.011 [CrossRef] [PubMed] [Google Scholar]
  • Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP, (2017) Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55: 2996–3005. doi: 10.1128/JCM.00921-17 [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.